Latest Cancer News

FDA Approves Kisqali as Initial Endocrine Therapy for Advanced Breast Cancer (07-23-2018)
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor... Continue Reading

Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN (07-19-2018)
Nimotuzumab in combination with concurrent radiotherapy and cisplatin provides significant clinical benefits in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). About... Continue Reading

FDA Approves Xtandi for Treatment of Castration-resistant Prostate Cancer (07-17-2018)
On July 13, 2018, the Food and Drug Administration approved Xtandi (enzalutamide) for patients with castration-resistant prostate cancer (CRPC).  This approval broadens the indicated patient population... Continue Reading

More Cancer News

Locations

 
 

The Center At Boca Raton
701 NW 13th St.
2nd Floor
Boca Raton, FL 33486
TEL: (561) 955-6400
FAX: (561) 750-7662

 
 
 

The Center At Delray Beach
6282 Linton Blvd.
Delray Beach, Florida 33484
TEL: (561) 495-8307
FAX: (561) 495-6422

 
 
 
Click here for the Lynn Cancer Institute